Synthesis of potent C2-symmetric, diol-based HIV-1 protease inhibitors.: Investigation of thioalkyl and thioaryl P1/P1′ substituents

被引：17

作者：

Mühlman, A

Classon, B

Hallberg, A

Samuelsson, B ^{[1
]}

机构：

[1] Stockholm Univ, Dept Organ Chem, Arrhenius Lab, SE-10691 Stockholm, Sweden

[2] Uppsala Univ, Dept Organ Pharmaceut Chem, BMC, SE-75123 Uppsala, Sweden

[3] Medivir AB, SE-14144 Huddinge, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2001年 / 44卷 / 21期

关键词：

D O I：

10.1021/jm0011169

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis of novel, potent diol-based HIV-1 protease inhibitors, having either -SAr, -SCH2-Ar, or -SCH2R groups as P1/P1' substituents is described. They can be prepared using a straightforward synthesis involving a thiol nucleophilic ring opening of a diepoxide. Inhibitor 13 was found to be a potent inhibitor of HIV-1 PR, showing good antiviral activity in a cell-based assay.

引用

页码：3402 / 3406

页数：5

共 50 条

[21] Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors.: Use of L-mannaric acid as a peptidomimetic scaffold
Alterman, M
Björsne, M
Mühlman, A
Classon, B
Kvarnström, I
Danielson, H
Markgren, PO
Nillroth, U
Unge, T
Hallberg, A
Samuelsson, B
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) : 3782 - 3792
[22] HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent
Duffy, JL
Kirk, BA
Kevin, NJ
Chapman, KT
Schleif, WA
Olsen, DB
Stahlhut, M
Rutkowski, CA
Kuo, LC
Jin, LX
Lin, JH
Emini, EA
Tata, JR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3323 - 3326
[23] HIV-1 PROTEASE INHIBITORS BASED ON HYDROXYETHYLENE DIPEPTIDE ISOSTERES - AN INVESTIGATION INTO THE ROLE OF THE P1' SIDE-CHAIN ON STRUCTURE ACTIVITY
YOUNG, SD
PAYNE, LS
THOMPSON, WJ
GAFFIN, N
LYLE, TA
BRITCHER, SF
GRAHAM, SL
SCHULTZ, TH
DEANA, AA
DARKE, PL
ZUGAY, J
SCHLEIF, WA
QUINTERO, JC
EMINI, EA
ANDERSON, PS
HUFF, JR
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) : 1702 - 1709
[24] High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations
Wannberg, J
Kaiser, NFK
Vrang, L
Samuelsson, B
Larhed, M
Hallberg, A
JOURNAL OF COMBINATORIAL CHEMISTRY, 2005, 7 (04): : 611 - 617
[25] Design, synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1′ ligand
Dou, Yue
Zhu, Mei
Dong, Biao
Wang, Ju-Xian
Zhang, Guo-Ning
Zhang, Fan
Wang, Yu-Cheng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (07)
[26] Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors
Huang, PP
Randolph, JT
Klein, LL
Vasavanonda, S
Dekhtyar, T
Stoll, VS
Kempf, DJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4075 - 4078
[27] P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1
Kim, RM
Rouse, EA
Chapman, KT
Schleif, WA
Olsen, DB
Stahlhut, M
Rutkowski, CA
Emini, EA
Tata, JR
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (18) : 4651 - 4654
[28] P1 and P1′ optimization of [3,4]-bicycloproline P2 incorporated tetrapeptidyl α-ketoamide based HCV protease inhibitors
Chen, SH
Lamar, J
Yip, Y
Victor, F
Johnson, RB
Wang, QM
Glass, JI
Heinz, B
Colacino, J
Guo, DQ
Tebbe, M
Munroe, JE
LETTERS IN DRUG DESIGN & DISCOVERY, 2005, 2 (02) : 118 - 123
[29] Synthesis of P1′-Functionalized Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol
De Rosa, Maria
Unge, Johan
Motwani, Hitesh V.
Rosenquist, Asa
Vrang, Lotta
Wallberg, Hans
Larhed, Mats
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6444 - 6457
[30] Design and synthesis of potent macrocyclic HIV-1 protease inhibitors involving P1-P2 ligands
Ghosh, Arun K.
Schiltz, Gary E.
Rusere, Linah N.
Osswald, Heather L.
Walters, D. Eric
Amano, Masayuki
Mitsuya, Hiroaki
ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, 12 (35) : 6842 - 6854

← 1 2 3 4 5 →